Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.

The global Peritoneal Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladder and rectum.

This report aims to provide a comprehensive presentation of the global market for Peritoneal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peritoneal Cancer.

Report Scope

The Peritoneal Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peritoneal Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peritoneal Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peritoneal Cancer Market Report

Report Metric	Details
Report Name	Peritoneal Cancer Market
Segment by Type	Surgery Chemotherapy (Anticancer Drugs) Radiotherapy (High-Energy Rays)
Segment by Application	Cancer Research Centers Cancer Hospital Surgical Centers Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, GlaxoSmithKline, Oxford BioMedica, Millennium Pharmaceuticals, Novartis, Bayer, Incyte, EntreMed, Oncolytics Biotech, Synta Pharmaceuticals, Oasmia Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peritoneal Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peritoneal Cancer Market report?

Ans: The main players in the Peritoneal Cancer Market are AstraZeneca, GlaxoSmithKline, Oxford BioMedica, Millennium Pharmaceuticals, Novartis, Bayer, Incyte, EntreMed, Oncolytics Biotech, Synta Pharmaceuticals, Oasmia Pharmaceutical

What are the Application segmentation covered in the Peritoneal Cancer Market report?

Ans: The Applications covered in the Peritoneal Cancer Market report are Cancer Research Centers, Cancer Hospital, Surgical Centers, Clinics

What are the Type segmentation covered in the Peritoneal Cancer Market report?

Ans: The Types covered in the Peritoneal Cancer Market report are Surgery, Chemotherapy (Anticancer Drugs), Radiotherapy (High-Energy Rays)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peritoneal Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Surgery

1.2.3 Chemotherapy (Anticancer Drugs)

1.2.4 Radiotherapy (High-Energy Rays)

1.3 Market by Application

1.3.1 Global Peritoneal Cancer Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cancer Research Centers

1.3.3 Cancer Hospital

1.3.4 Surgical Centers

1.3.5 Clinics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peritoneal Cancer Market Perspective (2019-2030)

2.2 Peritoneal Cancer Growth Trends by Region

2.2.1 Global Peritoneal Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Peritoneal Cancer Historic Market Size by Region (2019-2024)

2.2.3 Peritoneal Cancer Forecasted Market Size by Region (2025-2030)

2.3 Peritoneal Cancer Market Dynamics

2.3.1 Peritoneal Cancer Industry Trends

2.3.2 Peritoneal Cancer Market Drivers

2.3.3 Peritoneal Cancer Market Challenges

2.3.4 Peritoneal Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peritoneal Cancer Players by Revenue

3.1.1 Global Top Peritoneal Cancer Players by Revenue (2019-2024)

3.1.2 Global Peritoneal Cancer Revenue Market Share by Players (2019-2024)

3.2 Global Peritoneal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Peritoneal Cancer Revenue

3.4 Global Peritoneal Cancer Market Concentration Ratio

3.4.1 Global Peritoneal Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peritoneal Cancer Revenue in 2023

3.5 Peritoneal Cancer Key Players Head office and Area Served

3.6 Key Players Peritoneal Cancer Product Solution and Service

3.7 Date of Enter into Peritoneal Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Peritoneal Cancer Breakdown Data by Type

4.1 Global Peritoneal Cancer Historic Market Size by Type (2019-2024)

4.2 Global Peritoneal Cancer Forecasted Market Size by Type (2025-2030)

5 Peritoneal Cancer Breakdown Data by Application

5.1 Global Peritoneal Cancer Historic Market Size by Application (2019-2024)

5.2 Global Peritoneal Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Peritoneal Cancer Market Size (2019-2030)

6.2 North America Peritoneal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Peritoneal Cancer Market Size by Country (2019-2024)

6.4 North America Peritoneal Cancer Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peritoneal Cancer Market Size (2019-2030)

7.2 Europe Peritoneal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Peritoneal Cancer Market Size by Country (2019-2024)

7.4 Europe Peritoneal Cancer Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peritoneal Cancer Market Size (2019-2030)

8.2 Asia-Pacific Peritoneal Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Peritoneal Cancer Market Size by Region (2019-2024)

8.4 Asia-Pacific Peritoneal Cancer Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peritoneal Cancer Market Size (2019-2030)

9.2 Latin America Peritoneal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Peritoneal Cancer Market Size by Country (2019-2024)

9.4 Latin America Peritoneal Cancer Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peritoneal Cancer Market Size (2019-2030)

10.2 Middle East & Africa Peritoneal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Peritoneal Cancer Market Size by Country (2019-2024)

10.4 Middle East & Africa Peritoneal Cancer Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Detail

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Peritoneal Cancer Introduction

11.1.4 AstraZeneca Revenue in Peritoneal Cancer Business (2019-2024)

11.1.5 AstraZeneca Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Detail

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Peritoneal Cancer Introduction

11.2.4 GlaxoSmithKline Revenue in Peritoneal Cancer Business (2019-2024)

11.2.5 GlaxoSmithKline Recent Development

11.3 Oxford BioMedica

11.3.1 Oxford BioMedica Company Detail

11.3.2 Oxford BioMedica Business Overview

11.3.3 Oxford BioMedica Peritoneal Cancer Introduction

11.3.4 Oxford BioMedica Revenue in Peritoneal Cancer Business (2019-2024)

11.3.5 Oxford BioMedica Recent Development

11.4 Millennium Pharmaceuticals

11.4.1 Millennium Pharmaceuticals Company Detail

11.4.2 Millennium Pharmaceuticals Business Overview

11.4.3 Millennium Pharmaceuticals Peritoneal Cancer Introduction

11.4.4 Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2019-2024)

11.4.5 Millennium Pharmaceuticals Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis Peritoneal Cancer Introduction

11.5.4 Novartis Revenue in Peritoneal Cancer Business (2019-2024)

11.5.5 Novartis Recent Development

11.6 Bayer

11.6.1 Bayer Company Detail

11.6.2 Bayer Business Overview

11.6.3 Bayer Peritoneal Cancer Introduction

11.6.4 Bayer Revenue in Peritoneal Cancer Business (2019-2024)

11.6.5 Bayer Recent Development

11.7 Incyte

11.7.1 Incyte Company Detail

11.7.2 Incyte Business Overview

11.7.3 Incyte Peritoneal Cancer Introduction

11.7.4 Incyte Revenue in Peritoneal Cancer Business (2019-2024)

11.7.5 Incyte Recent Development

11.8 EntreMed

11.8.1 EntreMed Company Detail

11.8.2 EntreMed Business Overview

11.8.3 EntreMed Peritoneal Cancer Introduction

11.8.4 EntreMed Revenue in Peritoneal Cancer Business (2019-2024)

11.8.5 EntreMed Recent Development

11.9 Oncolytics Biotech

11.9.1 Oncolytics Biotech Company Detail

11.9.2 Oncolytics Biotech Business Overview

11.9.3 Oncolytics Biotech Peritoneal Cancer Introduction

11.9.4 Oncolytics Biotech Revenue in Peritoneal Cancer Business (2019-2024)

11.9.5 Oncolytics Biotech Recent Development

11.10 Synta Pharmaceuticals

11.10.1 Synta Pharmaceuticals Company Detail

11.10.2 Synta Pharmaceuticals Business Overview

11.10.3 Synta Pharmaceuticals Peritoneal Cancer Introduction

11.10.4 Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2019-2024)

11.10.5 Synta Pharmaceuticals Recent Development

11.11 Oasmia Pharmaceutical

11.11.1 Oasmia Pharmaceutical Company Detail

11.11.2 Oasmia Pharmaceutical Business Overview

11.11.3 Oasmia Pharmaceutical Peritoneal Cancer Introduction

11.11.4 Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2019-2024)

11.11.5 Oasmia Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

GlaxoSmithKline PLC

Oxford BioMedica

Millennium Pharmaceuticals

Synta Pharmaceuticals

Oasmia Pharmaceutical

List of Tables

Table 1. Global Peritoneal Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Surgery

Table 3. Key Players of Chemotherapy (Anticancer Drugs)

Table 4. Key Players of Radiotherapy (High-Energy Rays)

Table 5. Global Peritoneal Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Peritoneal Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Peritoneal Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Peritoneal Cancer Market Share by Region (2019-2024)

Table 9. Global Peritoneal Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Peritoneal Cancer Market Share by Region (2025-2030)

Table 11. Peritoneal Cancer Market Trends

Table 12. Peritoneal Cancer Market Drivers

Table 13. Peritoneal Cancer Market Challenges

Table 14. Peritoneal Cancer Market Restraints

Table 15. Global Peritoneal Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Peritoneal Cancer Market Share by Players (2019-2024)

Table 17. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peritoneal Cancer as of 2023)

Table 18. Ranking of Global Top Peritoneal Cancer Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Peritoneal Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Peritoneal Cancer Product Solution and Service

Table 22. Date of Enter into Peritoneal Cancer Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Peritoneal Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Peritoneal Cancer Revenue Market Share by Type (2019-2024)

Table 26. Global Peritoneal Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Peritoneal Cancer Revenue Market Share by Type (2025-2030)

Table 28. Global Peritoneal Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Peritoneal Cancer Revenue Market Share by Application (2019-2024)

Table 30. Global Peritoneal Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Peritoneal Cancer Revenue Market Share by Application (2025-2030)

Table 32. North America Peritoneal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Peritoneal Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Peritoneal Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Peritoneal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Peritoneal Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Peritoneal Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Peritoneal Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Peritoneal Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Peritoneal Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Peritoneal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Peritoneal Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Peritoneal Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Peritoneal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Peritoneal Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Peritoneal Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 47. AstraZeneca Company Detail

Table 48. AstraZeneca Business Overview

Table 49. AstraZeneca Peritoneal Cancer Product

Table 50. AstraZeneca Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 51. AstraZeneca Recent Development

Table 52. GlaxoSmithKline Company Detail

Table 53. GlaxoSmithKline Business Overview

Table 54. GlaxoSmithKline Peritoneal Cancer Product

Table 55. GlaxoSmithKline Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 56. GlaxoSmithKline Recent Development

Table 57. Oxford BioMedica Company Detail

Table 58. Oxford BioMedica Business Overview

Table 59. Oxford BioMedica Peritoneal Cancer Product

Table 60. Oxford BioMedica Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 61. Oxford BioMedica Recent Development

Table 62. Millennium Pharmaceuticals Company Detail

Table 63. Millennium Pharmaceuticals Business Overview

Table 64. Millennium Pharmaceuticals Peritoneal Cancer Product

Table 65. Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 66. Millennium Pharmaceuticals Recent Development

Table 67. Novartis Company Detail

Table 68. Novartis Business Overview

Table 69. Novartis Peritoneal Cancer Product

Table 70. Novartis Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 71. Novartis Recent Development

Table 72. Bayer Company Detail

Table 73. Bayer Business Overview

Table 74. Bayer Peritoneal Cancer Product

Table 75. Bayer Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 76. Bayer Recent Development

Table 77. Incyte Company Detail

Table 78. Incyte Business Overview

Table 79. Incyte Peritoneal Cancer Product

Table 80. Incyte Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 81. Incyte Recent Development

Table 82. EntreMed Company Detail

Table 83. EntreMed Business Overview

Table 84. EntreMed Peritoneal Cancer Product

Table 85. EntreMed Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 86. EntreMed Recent Development

Table 87. Oncolytics Biotech Company Detail

Table 88. Oncolytics Biotech Business Overview

Table 89. Oncolytics Biotech Peritoneal Cancer Product

Table 90. Oncolytics Biotech Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 91. Oncolytics Biotech Recent Development

Table 92. Synta Pharmaceuticals Company Detail

Table 93. Synta Pharmaceuticals Business Overview

Table 94. Synta Pharmaceuticals Peritoneal Cancer Product

Table 95. Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 96. Synta Pharmaceuticals Recent Development

Table 97. Oasmia Pharmaceutical Company Detail

Table 98. Oasmia Pharmaceutical Business Overview

Table 99. Oasmia Pharmaceutical Peritoneal Cancer Product

Table 100. Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)

Table 101. Oasmia Pharmaceutical Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Peritoneal Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Peritoneal Cancer Market Share by Type: 2023 VS 2030

Figure 3. Surgery Features

Figure 4. Chemotherapy (Anticancer Drugs) Features

Figure 5. Radiotherapy (High-Energy Rays) Features

Figure 6. Global Peritoneal Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Peritoneal Cancer Market Share by Application: 2023 VS 2030

Figure 8. Cancer Research Centers Case Studies

Figure 9. Cancer Hospital Case Studies

Figure 10. Surgical Centers Case Studies

Figure 11. Clinics Case Studies

Figure 12. Peritoneal Cancer Report Years Considered

Figure 13. Global Peritoneal Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Peritoneal Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Peritoneal Cancer Market Share by Region: 2023 VS 2030

Figure 16. Global Peritoneal Cancer Market Share by Players in 2023

Figure 17. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peritoneal Cancer as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Peritoneal Cancer Revenue in 2023

Figure 19. North America Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Peritoneal Cancer Market Share by Country (2019-2030)

Figure 21. United States Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Peritoneal Cancer Market Share by Country (2019-2030)

Figure 25. Germany Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Peritoneal Cancer Market Share by Region (2019-2030)

Figure 33. China Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Peritoneal Cancer Market Share by Country (2019-2030)

Figure 41. Mexico Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Peritoneal Cancer Market Share by Country (2019-2030)

Figure 45. Turkey Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. AstraZeneca Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 48. GlaxoSmithKline Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 49. Oxford BioMedica Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 50. Millennium Pharmaceuticals Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 51. Novartis Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 52. Bayer Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 53. Incyte Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 54. EntreMed Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 55. Oncolytics Biotech Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 56. Synta Pharmaceuticals Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 57. Oasmia Pharmaceutical Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pediatric Cardiac Tumor Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G6046

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Interventional Oncology Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20U7613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions